Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Company

Mereo BioPharma Group

Tracked across 1 events · 7 articles · First seen Apr 01, 2026 · Last active May 14, 2026

Sentiment
-50
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 -50
Business
Impact: Mereo BioPharma Group is facing a securities class action lawsuit for allegedly disseminating false and misleading statements regarding its Phase 3 clinical trials, causing investors to purchase its ADSs at inflated prices.
Apr 01, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Mereo BioPharma Group live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.